IMMUNOTENSION

Inflammation and Immunity in Human Hypertension and Vascular Dysfunction

 Coordinatore UNIVERSITY OF GLASGOW 

 Organization address address: University Avenue
city: GLASGOW
postcode: G12 8QQ

contact info
Titolo: Mr.
Nome: Joe
Cognome: Galloway
Email: send email
Telefono: +44 141 330 3884

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 100˙000 €
 EC contributo 100˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2013-CIG
 Funding Scheme MC-CIG
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-05-01   -   2018-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF GLASGOW

 Organization address address: University Avenue
city: GLASGOW
postcode: G12 8QQ

contact info
Titolo: Mr.
Nome: Joe
Cognome: Galloway
Email: send email
Telefono: +44 141 330 3884

UK (GLASGOW) coordinator 100˙000.00

Mappa

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

leukocytes    observations    dysfunction    human    hypertension    cells    vascular    immune    monocytes    patients    unclear    renal    disease    mechanisms    perivascular    hypertensive    subsequently    treatment    involvement   

 Obiettivo del progetto (Objective)

'Hypertension is a major cause of death and disability in Europe and in the rest of the World. It affects 30% of adults, and additional 30% are at very high risk of developing hypertension. This is an enormous health problem as it is a cause of subsequent renal failure, stroke, myocardial infarction and heart failure. Despite extensive research, the mechanisms of most cases of hypertension remain unclear. In spite of therapies available, over 40% of treated patients do not reach treatment goals and present with uncontrolled disease. Since the mid-1980s, no new classes of drugs have been successfully developed to treat hypertension. We and others have recently made observations providing a novel mechanism for hypertension involving activation of the immune system, with involvement of T lymphocytes, monocytes and dendritic cells. Mice lacking T cells or monocytes are protected from severe hypertension and renal/vascular dysfunction. Perivascular and renal infiltration of these cells producing cytokines such as IL-17 and TNF-alpha has been implicated. The exact mechanisms or relevance of these observations for human hypertension is unclear. Therefore, we propose to investigate the involvement of the immune system in human hypertension. First, we propose to analyse in depth the characteristics of leukocytes in hypertensive patients in comparison to normotensive controls. Subsequently we will focus on leukocytes infiltrating perivascular adipose tissue and cortex and medulla of the kidney in hypertension in relation to detailed clinical phenotypes of the disease such as ambulatory blood pressure monitoring or vascular dysfunction. Subsequently we will perform ex vivo functional studies by co-incubation of reporter vessels with hypertensive T cells (other leukocytes) to examine their role in vascular dysfunction. These interdisciplinary studies of hypertension have the potential of providing a new understanding and possibly treatment of this otherwise devastating disease.'

Altri progetti dello stesso programma (FP7-PEOPLE)

NANHEMO (2008)

Nanobiosensors for Health Monitoring

Read More  

THE NASCENT CODE (2014)

Unravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expression

Read More  

LENSMAGPAU (2011)

Studying Gravitational Lensing Magnification with PAU and other Surveys

Read More